University of North Carolina- Chapel Hill
Welcome,         Profile    Billing    Logout  
 6 Trials 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Reuland, Daniel
SCORE, NCT04406714: Scaling CRC Screening Through Outreach, Referral, and Engagement

Completed
N/A
4318
US
Trial Mailed FIT Intervention - Age Group 50-75, Sub-Study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49, Sub-Study Mailed FIT Active Comparator Plain Envelope - Age Group 45-49
UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI), East Carolina University
Colorectal Cancer
03/23
09/24
Johns, Ashley
REGEN-006, NCT05099770: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Recruiting
3
685
Europe, Canada, US, RoW
Renal Autologous Cell Therapy (REACT), Sham Comparator
Prokidney, Iqvia Pty Ltd, PPD
Type 2 Diabetes Mellitus, Chronic Kidney Diseases
02/27
02/27
NCT05286853 / 2022-000289-16: A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease

Withdrawn
3
600
Europe
Renal Autologous Cell Therapy (REACT), Sham Comparator
Prokidney, Iqvia Pty Ltd
Type 2 Diabetes Mellitus, Chronic Kidney Diseases
09/24
09/24
NCT02836574: A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Completed
2
83
US
Renal Autologous Cell Therapy (REACT), Rilparencel, Renal Biopsy, Kidney Biopsy
Prokidney, CTI Clinical Trial and Consulting Services
Type 2 Diabetes Mellitus, Chronic Kidney Disease
12/23
12/23
NCT05018416: Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Active, not recruiting
2
53
US
Renal Autologous Cell Therapy (REACT)
Prokidney
Chronic Kidney Diseases, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
06/26
09/26
NCT04115345: A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

Completed
1
6
US
Renal Autologous Cell Therapy (REACT)
Prokidney, CTI Clinical Trial and Consulting Services
Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract
01/23
01/23
NCT05694169: A Study of Participants With Chronic Kidney Disease Previously Treated With REACT

Recruiting
1
10
US
Renal Autologous Cell Therapy (REACT)
Prokidney
Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases
03/25
06/25
NCT05918523: A Long-Term Follow-Up Study of Participants Exposed to REACT

Recruiting
N/A
80
US
Renal Autologous Cell Therapy (REACT)
Prokidney
Diabetic Kidney Disease, Chronic Kidney Diseases
01/28
03/28
Brenner, Alison

Not yet recruiting
N/A
1500
NA
PharmFIT
UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI), Fred Hutchinson Cancer Center
Colorectal Cancer
01/28
01/29
HEALS, NCT06070870: Health Education Approach to Lung Screening

Recruiting
N/A
225
US
Patient Navigation
Virginia Commonwealth University, Stand Up To Cancer
Lung Cancer
03/26
04/26
Detwiler, Randy
REGEN-006, NCT05099770: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Recruiting
3
685
Europe, Canada, US, RoW
Renal Autologous Cell Therapy (REACT), Sham Comparator
Prokidney, Iqvia Pty Ltd, PPD
Type 2 Diabetes Mellitus, Chronic Kidney Diseases
02/27
02/27
Ferrari, Renee
No trials found
Minser, Jenna
No trials found

Download Options